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Synesthesia, a neurological condition affecting between 0.05%–1% of the population, is characterized by anomalous sensory perception
and associated alterations in cognitive function due to interference from synesthetic percepts. A stimulus in one sensory modality trig-
gers an automatic, consistent response in either another modality or a different aspect of the same modality. Familiality studies show
evidence of a strong genetic predisposition; whereas initial pedigree analyses supported a single-gene X-linked dominant mode of inher-
itance with a skewed F:M ratio and a notable absence of male-to-male transmission, subsequent analyses in larger samples indicated that
the mode of inheritance was likely to be more complex. Here, we report the results of a whole-genome linkage scan for auditory-visual
synesthesia with 410 microsatellite markers at 9.05 cM density in 43 multiplex families (n ¼ 196) with potential candidate regions ﬁne-
mapped at 5 cM density. Using NPL and HLOD analysis, we identiﬁed four candidate regions. Signiﬁcant linkage at the genome-wide
level was detected to chromosome 2q24 (HLOD ¼ 3.025, empirical genome-wide p ¼ 0.047). Suggestive linkage was found to chromo-
somes 5q33, 6p12, and 12p12. No support was found for linkage to the X chromosome; furthermore, we have identiﬁed two conﬁrmed
cases of male-to-male transmission of synesthesia. Our results demonstrate that auditory-visual synesthesia is likely to be an oligogenic
disorder subject tomultiple modes of inheritance and locus heterogeneity. This study comprises a signiﬁcant step toward identifying the
genetic substrates underlying synesthesia, with important implications for our understanding of the role of genes in human cognition
and perception.Results and Discussion
Synesthesia is a neurodevelopmental condition affecting
between 0.05%–1% of the population1–3 in which a stim-
ulus in one sensory modality triggers an automatic, con-
sistent response in another modality (e.g., sound triggers
the perception of color)4,5 or in a different aspect of the
same modality (e.g., black text triggers the perception of
color).6,7 There is growing evidence that the simultaneous
perception of normal and synesthetic percepts results in
perceptual and cognitive dysfunction affecting linguistic6
and numerical8 processing, and in severe cases sensory
overload can interfere with the ability of affected individ-
uals to lead a normal life.2,9 Conversely, synesthesia has
been shown to result in ‘‘positive’’ cognitive alterations,
including improved recall10,11 and elevated performance
on perceptual tests,7 and has been anecdotally connected
with absolute pitch (MIM 159300)12 and eidetic me-
mory.9,13 Neuroimaging studies indicate that synesthesia
results from altered neural connectivity, with conﬁrmation
of anomalous activation in brain regions involved in color
processing when synesthetes are exposed to a synesthetic
trigger14 and observation of alterations in white matter
that could indicate the existence of increased connectivity
in the brains of synesthetes.15
The familiality of synesthesia was ﬁrst noted by Sir Fran-
cis Galton in 1883.16 Modern familiality studies showThe Americevidence for a strong genetic component, with>40% prev-
alence among the ﬁrst-degree relatives of synesthetes.1,2
Early pedigree analyses of families containing multiple
synesthetes2,17 supported the theory that synesthesia is
a highly penetrant Mendelian disorder showing a major
gene effect and a dominant (possibly X-linked) mode of
inheritance. More females are affected than males, and
there is a notable absence of conﬁrmed cases of male-to-
male transmission. However, further studies in larger
samples indicate that the female predominance is not as
great as previously believed and that the mode of inheri-
tance is likely to be more complex.1,18
We conducted what is to our knowledge the ﬁrst
whole-genome scan for susceptibility genes linked to
synesthesia in a sample of 43 multiplex families with
auditory-visual synesthesia (n ¼ 196, 121 affected, 68
unaffected, 7 phenotype unknown) recruited from the
Cambridge Synaesthesia Research Group database. All
auditory-visual synesthetes who had reported relatives
with synesthesia on a preliminary screening question-
naire were contacted for a screening interview, and fami-
lies with a history of neurological, ophthalmological, or
psychiatric disorders or a positive drug history were
excluded. Nineteen families (wave 1) were recruited
during the initial recruitment period, and 24 families
(wave 2) were recruited during the second recruitment
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Clinical evaluation and phenotyping were performed
with the Baron-Cohen et al. 1996 Test of Genuineness2
(wave 1) and the Asher et al. Revised Test of Genuineness19
(wave 2); an analysis of test results from nine individuals
tested with both tests indicates that they are highly corre-
lated (r ¼ 0.905). Genomic DNA was extracted from blood
(wave 1) or buccal swabs (wave 2) with Nucleon kits (Tep-
nel Life Sciences PLC) and from Oragene saliva kits
(wave 2) (DNA Genotek). DNA samples underwent
whole-genome ampliﬁcation with GenomiPhi v2 (GE
Healthcare). Written informed consent was given by all
subjects, and where appropriate by parents or guardians.
The study protocol followed the standards laid out in the
Declaration of Helsinki and was reviewed and approved
by the Local Research Ethics Committee of the Cambridge
University Hospitals NHS Foundation Trust.
Prior to commencing the genome scan, we performed
computer simulations in SLINK20 using the best available
data on prevalence and mode of inheritance to conﬁrm
the power of the sample to detect a major gene effect.
The genome scan utilized 410 highly polymorphic micro-
satellite markers (mean intermarker distance ¼ 9.05 cM
(SEM ¼ 0.21), with mean information content ¼ 0.710
(SEM ¼ 0.003). The Applied Biosystems (ABI) PRISM LMS
v2.5 10 cM density microsatellite marker set supplied the
core markers. Markers from the ABI LMS v2.5 5 cM marker
set or custom markers designed with Primer321 were used
whenmarkers in the core set failed to produce usable geno-
types after aminimumof three PCRs with at least two sepa-
rate primer aliquots. Markers were also added to regions of
the genome where information content was <60%. Geno-
typing was performed with ABI 377 and 3700 sequencing
machines and GENESCAN/GENOTYPER software (Applied
Biosystems). We used GAS v2.022 and PEDCHECK23 to
Table 1. Loci with Multipoint NPL LOD Scores > 2 after Fine-
Mapping of Potential Candidate Regions
Chr Marker
Physical
Position
Genetic
Position (cM) LOD p value
Size of Linkage
Peak (cM)
5 D5S436 5q32 150.91 1.08 0.013
5 D5S2090* 5q33.1 153.6 2.3 0.0006 14.61
5 D5S2049 5q33.3 165.52 1.82 0.002
6 D6S282 6p21.1 69.99 1.83 0.002
6 D6S1650 6p21.1 72.73 1.91 0.0015
6 D6S272* 6p12.3 77.76 2.37 0.0005 13.03
6 D6S257 6q12.1 83.02 1.63 0.003
6 D6S460 6q14.1 94.44 1.17 0.01
6 D6S462 6q15 101.7 2.03 0.0011 11.01
6 D6S300 6q16.1 105.45 1.24 0.008
17 D17S798 17q11.2 58.69 1.79 0.002
17 D17S927 17q12 66.04 2.05 0.001 11.41
17 D17S1814 17q12-21 70.1 1.27 0.008
The data were generated in MERLIN 1.1a. Genetic position is the relative
position from pter to qter in cM. The locus generating the highest LOD score
for each peak is notated in bold. Asterisks indicate a locus meeting the
Lander and Kruglyak criteria for suggestive linkage (LOD > 2.2). The size
of a linkage peak is defined as the region encompassing a one-LOD drop
on either side of the marker with the highest LOD score.280 The American Journal of Human Genetics 84, 279–285, Februardetect Mendelian inheritance errors and performed haplo-
type analysis with GENEHUNTER 2.0 and X-GENEHUN
TER-PLUS v1.3.24 We performed a ﬁnal check for statisti-
cally unlikely genotypes with the error-checking algorithm
in MERLIN/MERLIN-IN-X (MINX) 1.1a.25
An initialmultipoint parametric linkage analysiswas per-
formed withMERLIN/MINX 1.1a under a dominant model
constructed with pedigree analysis and the most conserva-
tive parameters from the available prevalence data. How-
ever, preliminary analysis indicated that the parametric
model was a poor ﬁt for the experimental data, suggesting
genetic heterogeneity. Thus, a nonparametric approach
was adopted for the full analysis of the genome scan.
Multipoint nonparametric linkage (NPL) analysis was
performed with MERLIN/MINX 1.1a. Because of the rela-
tively small number of families, the Whittemore and
Halpern NPLall statistic
26 was calculated with the Kong
and Cox (1997) exponential function.24 Fifteen potential
candidate regions with LOD > 1 on 11 chromosomes
(see Figure S1 and Table S1 available online) were detected.
These regions were mapped further with additional micro-
satellites (mean intermarker distance 5.00 cM (SEM ¼
0.34), mean information content 0.78 (SEM 0.005) across
ﬁne-mapped regions). NPL analysis of the ﬁne-mapped
regions revealed four regions with LOD > 2, of which
two had LOD > 2.2 on chromosomes 5q33 (D5S2090,
LOD ¼ 2.3, p ¼ 0.0006) and 6p12.3 (D6S272, LOD ¼
2.37, p ¼ 0.0005), the threshold for suggestive linkage
put forth by Lander and Kruglyak27 (see Table 1). All
regions with LOD > 2 were supported by single-point
LOD scores > 1 from at least three markers.
Additionally, a multipoint HLOD score analysis was per-
formed with MERLIN under models derived from the best
available estimates after pedigree analysis. Disease allele
frequency was derived from published prevalence
studies;2,3 given that there is controversy regarding the
prevalence of auditory-visual synesthesia (with estimates
ranging from 0.05% to 1%), the conservative estimate
was used (GF ¼ 0.01). An examination of the pedigrees
revealed a dominant inheritance pattern (see Figure S2).
Given that skipping of generations has been observed in
both our sample and those examined in the prevalence
studies, the initial penetrance for the dominant model
was set at 0.90, with further penetrances of 0.85, 0.75,
and 0.65. Because a recessive mode of inheritance for
a particular locus could not be ruled out entirely in the
context of heterogeneity, a recessive model at pene-
trance ¼ 0.75 was also tested. The following three models
yielded the best ﬁt: dominant with penetrance ¼ 0.65,
dominant with penetrance ¼ 0.90, and recessive with
penetrance ¼ 0.75. The analysis was run with the ﬁne-
mapping data where available and data from the primary
genome scan for the remainder of the genome.
Genome-wide empirical p values were calculated with
the gene-drop function in MERLIN, with the null distribu-
tion estimated over all genetic models in each simulation
to correct for multiple testing. One thousand replicatesy 13, 2009
Table 2. Loci with Multipoint HLOD Scores >2.03 Supported by Multiple Markers
Chr Marker
Physical
Position
Genetic
Position
(cM) a HLOD
Empirical
p Value
Model,
Penetrance
Single-Point
HLOD
NPL (full
sample)
NPL
(contributing
families)
Size of
Linkage
Peak (cM)
2 D2S151 2q22.3 165.9 0.487 2.577 0.153 dom, 0.90 2.622 0.73 2.13
2 D2S142 2q24.1 174.79 0.555 3.025 0.047 dom, 0.90 1.321 0.92 2.59 15.88
2 D2S2330 2q24.3 181.78 0.448 2.442 0.202 dom, 0.90 1.751 1.01 3.03
6 D6S1650 6p21.1 72.73 0.379 1.468 0.891 dom, 0.65 1.116 1.91 2.66
6 D6S272 6p12.3 77.76 0.407 2.272 0.275 dom, 0.65 2.002 2.37 3.10 10.29
6 D6S257 6p12.1 83.02 0.341 1.181 0.988 dom, 0.65 0.680 1.63 2.80
12 D12S310 12p12.3 39.13 0.438 2.675 0.118 rec, 0.75 1.038 0.95 1.55
12 D12S1617 12p12.1 48.09 0.484 2.849 0.073 rec, 0.75 2.226 0.23 0.94 14.92
12 D12S345 12p11.2 57.58 0.346 1.562 0.835 rec, 0.75 1.593 0.10 1.20
The data were generated in Merlin 1.1a. LOD ¼ 2.03 is the threshold for suggestive linkage by gene-drop simulations. Data from the fine-mapping study
were used for chromosomes 2, 5, 6, 8, 10, 11, 13, 15, and 17; data for all other chromosomes are from the primary genome scan. Alpha (a) refers to the
proportion of families linked to that locus. Genetic position is the relative position from pter to qter in cM. The locus generating the highest multipoint
HLOD score for each peak is notated in bold. Contributing families are those showing linkage to the HLOD peak. The size of a linkage peak is defined as the
region encompassing a one-LOD drop on either side of the marker with the highest LOD score.were generated under the null hypothesis of no linkage
anywhere in the genome. The original pedigree structures
and missing data patterns were retained to reﬂect the real
data. Suggestive and signiﬁcant linkage thresholds
observed under the null hypothesis were calculated across
the entire marker set. In accordance with the recommen-
dations of Lander and Kruglyak, the cutoff for suggestive
linkage was deﬁned as the maximum LOD score expected
to occur once per genome scan by chance alone (that is,
1000 LOD scores of equal or greater size were observed in
1000 simulations); the signiﬁcant linkage threshold was
deﬁned as the maximum LOD score occurring with proba-
bility 0.05 in a genome scan (that is, 50 LOD scores of
equal or greater size observed in 1000 simulations); and
the highly signiﬁcant linkage threshold was deﬁned as
the maximum LOD score occurring with probability
0.001 in a genome scan (that is, 1 LOD score of equal or
greater size observed in 1000 simulations). The simulations
yielded empirical genome-wide signiﬁcance thresholds of
2.03 for suggestive linkage, 2.97 for signiﬁcant linkage
(p < 0.05), and 5.70 for highly signiﬁcant linkage (p <
0.001). The empirical p value for a peak obtained with
true data is determined by counting how often a simulated
unlinked LOD score of greater or equal value to the
observed result is seen in 1000 simulations.
The HLOD analysis revealed one region of signiﬁcant
linkage at D2S142 on chromosome 2q24.1 (HLOD ¼
3.025, empirical genome-wide p ¼ 0.047) and three
regions with evidence of suggestive linkage on chromo-
somes 6p12.3 (D6S272, HLOD ¼ 2.272, empirical
genome-wide p ¼ 0.275), 12p12.1 (D12S1617, HLOD ¼
2.849, empirical p ¼ 0.073), and 9q33.1 (D9S1776,
HLOD ¼ 2.473, empirical p ¼ 0.188). A total of 23 regions
obtained HLOD > 1 in this analysis; 12 of these, including
the suggestive linkage peak on chromosome 6, were
detected by the NPL analysis (see Tables S2 and S3).
Single-point HLOD scores generated under the same
parameters supported the results on chromosomes 2, 6,The Americand 12 (see Table 2). However, the region on chromosome
9 was supported by only one marker in the single-point
analysis, thereby raising the question of statistical artifact.
For this reason, this locus was not considered a candidate
region for the purposes of the discussion below. To further
investigate the likelihood that the peaks detected by the
HLOD represented real signals, we performed an additional
set of NPL analyses focusing on the subsets of families
contributing to each HLOD peak (see Table 2 and
Figure S3). This analysis shows a signiﬁcant increase in
LOD score over the initial NPL analysis, indicating that
the presence of signiﬁcant heterogeneity at these loci was
likely to have diminished the linkage signal in these
regions and providing strong support for the HLOD result.
In sum, four candidate regions met criteria for suggestive
or signiﬁcant evidence for linkage with NPL or HLOD anal-
ysis. No support was found for linkage to the X chromo-
some in either analysis (maximum LOD ¼ 0.62 in the
NPL analysis). Furthermore, two families demonstrating
what are to our knowledge the ﬁrst conﬁrmed cases of
male-to-male transmission of synesthesia, with paternity
veriﬁed through the genome scan, have been identiﬁed
as part of this study (see Figure 1).
These ﬁndings have important implications for our over-
all understanding of the genetics of synesthesia, indicating
that the genetic basis of synesthesia is rather more
complex than originally believed. Rather than a single
gene at a single locus, the results of the heterogeneity anal-
ysis support multiple modes of inheritance for different
loci. The discovery of multiple peaks with relatively small
genetic effects and the detection of signiﬁcant linkage on
chromosome 2q and suggestive linkage on chromosome
12p during the HLOD analysis when no signiﬁcant linkage
was found during the NPL analysis is consistent with
a complex disorder with considerable genetic heteroge-
neity; the increase in the NPL LOD score observed when
the heterogeneity in the sample was reduced provides
further supporting evidence. This could potentially meanan Journal of Human Genetics 84, 279–285, February 13, 2009 281
Figure 1. Pedigrees of Families with
Male-to-Male Transmission of Auditory-
Visual Synesthesia
Hatched ¼ phenotype unknown. Asterisks
indicate an individual from whom DNA
was obtained.a number of causative loci with different loci producing
the clinical phenotype in particular families, consistent
with ﬁndings in other neurodevelopmental disorders
such as dyslexia (MIM 127700)28 and speciﬁc language
impairment (MIM 606711)29 in which both epistatic
(gene-gene) interactions and gene-environment interac-
tions are believed to play an important role.
Distinguishing the true mode of inheritance will require
signiﬁcant further investigation that uses a much larger
familial sample with precise phenotyping and subpheno-
typing and higher marker density. The use of additional
phenotyping methods, notably neuroimaging, to further
deﬁne subgroups within the synesthetic population would
provide important additional information that could facil-
itate the search for susceptibility genes. However, even
then it may not be possible to specify a single mode of
inheritance for synesthesia; even if most cases are due to
oligogenic inheritance, it is probable that there are indi-
vidual families that show Mendelian inheritance, as in
other neurodevelopmental disorders such as speciﬁc
language impairment30 and autism spectrum disorders
(ASDs; MIM 209850).31 The detailed analysis of such fami-
lies with known chromosomal abnormalities or detectable
copy-number variants may enable the identiﬁcation of
candidate genes and the delineation of pathways that
play an important role in the etiological process.
Although the resolution of the scan makes identifying
potential candidate genes within the candidate regions
challenging, the uncertainty about the etiology of synes-
thesia makes the genetic location of the region of signiﬁ-
cant linkage of particular interest. The marker obtaining
the highest LOD score (D2S142, with HLOD ¼ 3.025) has
been linked to autism.32 Synesthesia is sometimes reported
as a symptom in autism-spectrum disorders,33 and sensory
and perceptual abnormalities are a signiﬁcant feature of
ASDs.34,35 Clinical reports indicate a potentially elevated
prevalence of synesthesia among people with autism-spec-
trum disorders, as well as sensory overload similar to that
reported by synesthetes (S.B.-C., unpublished data). Audi-
tory stimuli trigger responses in both auditory and nearby
visual brain regions in autistic individuals36 as well as audi-
tory-visual synesthetes.14 Neuropathological studies have
detected abnormally increased connectivity in the brains
of individuals with autism,37 and alterations in white
matter that could indicate increased connectivity have
been observed in the brains of synesthetes;15 neuropatho-282 The American Journal of Human Genetics 84, 279–285, Februarlogical studies of the brains of synesthetes would
contribute signiﬁcantly to the further elucidation of the
underlying neural architecture. A recent case study indi-
cates that savantism, long thought to be connected with
autism, may in some cases result from the combination
of autism and synesthesia.38
There are a number of interesting candidate genes in this
region. TBR1 (MIM 604616) induces the transcription of
genes regulated by the T-box element,39,40 including reelin
(RELN [MIM 600514]), a gene that plays a vital role in the
development of the cerebral cortex. Neuropathological
examination of the brains of tbr1 knockout mice shows
abnormalities in the laminar organization of the cortex;
these abnormalities could theoretically contribute to the
altered neural connectivity observed in synaesthetes.41,42
Defects in the sodium channel alpha-subunit genes
SCN1A (MIM 182389) and SCN2A (MIM 182390), which
encode voltage-gated sodium channels throughout the
central nervous system,43,44 have been identiﬁed as causes
of generalized epilepsy with febrile seizures (MIM 604233)
(SCN1A)45,46 and benign familial neonatal-infantile
seizures (MIM 607745) (SCN2A).47,48 The pathogenesis of
epilepsy as ectopic activity in the brain caused by under-
lying alterations in the connectivity and excitability of
neuronal networks49 has interesting implications for synes-
thesia, in which a lowered excitability threshold could
result in increased crosstalk between neurons. Rare muta-
tions of TBR1, SCN2A, and neighboring gene SCN3A have
been observed in familial autism.50,51 Other noteworthy
candidate genes in this region include GALNT13 (MIM
608369), a gene encoding a UDP-N-acetyl-alpha-D-galacto-
samine:polypeptide N-acetylgalactosaminyltransferase
that is expressed solely in neurons, in which it synthesizes
GalNAc alpha-serine/threonine antigen,52 and ERMN
(MIM 610072), a homolog of the mouse gene ermin that is
expressed exclusively on oligodendrocytes in mice and up-
regulated during the period of active myelination of CNS
axons in rats.53
Interesting candidate genes for neurological and
psychiatric disorders and CNS development are also
located in the regions of suggestive linkage. The region
on chromosome 6 detected by both NPL and HLOD anal-
yses has been strongly linked to dyslexia and speciﬁcally
to difﬁculties in phonological decoding and orthographic
processing,54,55 which is of particular interest given the
importance of linguistic stimuli in synesthesia. Two genesy 13, 2009
in this region, KIAA0319 (MIM 609269)56 and DCDC2
(MIM 605755),57 have been proposed as candidate genes
for dyslexia; both have been shown to play roles in
neuronal migration, which has important implications
for synesthesia given the evidence for altered neural archi-
tecture in the disorder. This region has also been linked to
juvenilemyoclonic epilepsy (MIM606904), and a causative
gene (EFHC1 [MIM 608815]) has been identiﬁed;58 this
gene plays a role in apoptosis, with the mutations seen
in epileptic families lowering its apoptotic effect. A muta-
tion with similar effect in synesthetes could play a role in
the retention of neonatal synesthetic pathways.
The region on chromosome 12 detected in the HLOD
analysis contains the N-methyl-D-aspartate (NMDA)
receptor 2B subunit geneGRIN2B (MIM 138252). Of partic-
ular interest in the context of the eidetic aspects of syn-
esthesia is the evidence that NMDA receptors play a vital
role in long-term potentiation and the consolidation of
learning and memory.59 Mutations in this gene have
been shown to affect both learning and memory stability,
with overexpression resulting in enhanced learning and
memory in mice,60 which is particularly notable given
new evidence for the role synesthesia may play in savan-
tism.38 It has been further linked to autism.61
The region on chromosome 5q identiﬁed in the NPL
analysis includes DPYSL3 (MIM 601168), a gene involved
in neural plasticity, axonal growth and guidance, and
neuronal differentiation.62 In addition to being a good
candidate given the known alternations in neural architec-
ture in synesthetes, DPYSL3 is highly expressed in the late-
fetal and early-postnatal brain and spinal cord but not in
the adult brain,63 thereby making it an interesting candi-
date in the context of the evidence for a universal
‘‘neonatal synesthesia’’ that disappears over the course of
normal development.
Formerly an obscure condition, synesthesia has attracted
growing interest for its potential to advance our under-
standing of human cognition and perception. A greater
understanding of the neural mechanisms underlying
synesthesia will offer insight into typical as well as atypical
cognitive development. Improved understanding of synes-
thesia has important implications for other neurodevelop-
mental disorders, many of which (e.g., autism spectrum
disorders,33 Williams-Beuren syndrome [MIM 194050]64)
involve abnormal sensory perception. Auditory-visual syn-
esthetes link low musical pitches to dark colors and high
pitches to light colors5—a pattern previously noted in
nonsynesthetes—and similar trends have been detected
in the grapheme-color pairings of synesthetes and nonsy-
nesthetes,65 implying that synesthesia stems from
mechanisms common to all humans. Moreover, because
synesthetic perception occurs in the absence of direct
sensory stimulation, it may illuminate how the human
brain integrates sensory data into conscious perception
and may even shed light on the neural basis of conscious-
ness.66 The eventual identiﬁcation and functional charac-
terization of susceptibility genes linked to synesthesia willThe Americayield fundamental insights into the role of heredity in
human cognition and perception.
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